CONTEXT: Complex karyotypes in acute myeloid leukemia (AML) are characterized by an overall low response rate with frequent relapses after clinical treatment. CASE REPORT: Here, we describe the case of a 61-year-old obese female with clinically diagnosed AML who presented a complex karyotype involving an uncommon abnormality: ring chromosome 11. Immunophenotypic analysis confirmed the diagnosis. Classical and molecular cytogenetic analyses, using GTG banding and FISH (fluorescence in situ hybridization), revealed the presence of complex structural rearrangement involving r(11), add(12)(p13), der(5) and der(13). CONCLUSION: Molecular cytogenetic analysis is suitable for better identification and characterization of chromosomal rearrangements in AML. Case reports like this, as well as population-based studies, are necessary for understanding the karyotypic changes that occur in humans.
INTRODUCTION
Acute myeloid leukemia (AML) is a heterogeneous group of diseases. In some cases, patients have satisfactory survival, whereas in others, the course has a dismal prognosis. The risk factors include obesity and chromosomal aberrations. Recent studies have suggested that obesity is a risk factor associated with AML. [1] [2] [3] Classically, karyotyping has formed a powerful independent prognostic indicator in this group of diseases. 4, 5 It serves to identify biologically distinct subsets of disease and has been widely used to provide the framework for risk-adapted treatment approaches. Three subgroups can be distinguished:
1. AML with normal karyotype;
2. AML with primary balanced chromosomal aberrations; and 3. AML with unbalanced karyotype abnormalities characterized by gains and/or losses of usually larger regions of the genome and no known primary balanced abnormality. 4 Complex karyotypes are defined as three or more independent chromosomal abnormalities in one genome. AML patients with such abnormalities are characterized by a low overall response rate, and often present relapses after clinical treatment. 5 Ring chromosomes are considered to be a rare finding in these diseases. 6 Here, we describe a case with a complex karyotype involving uncommon chromosomal abnormalities in an obese patient. We also present a review of the literature focusing on studies in which ring chromosome 11 was found in AML cases.
CASE REPORT
A 61-year-old woman was registered at Pedro Ernesto University Hospital (HUPE) in December 2010, with a three-month history of dizziness, precordial pain and adynamia, a weight loss of The patient was treated with one cycle of cytarabine and daunorubicin to induce remission and four consolidation cycles of cytarabine. Hematological remission was achieved after the first cycle of cytarabine/daunorubicin (one month afterwards).
Nevertheless, she relapsed in August 2011. At that time, a myelogram showed the presence of blasts ( Figure 1 ) and an immunophenotypic analysis revealed that the blasts were 71.2% positive for HLADR, CD33, CD38, CD117, CD13, CD15, CD64, CD33, CD13
and CD14. The immunophenotypic profile of this case at relapse is shown in Figure 2 . A molecular analysis was positive for AML- (Figure 3 ).
For further clarification, fluorescence in situ hybridization (FISH) was performed, applying whole chromosome probes (wcp) for
The exclusion criteria were:
1. Articles published outside of proposed period;
2. Other published articles not specified in the inclusion criteria;
3. Clinical research articles on children;
4. Experimental clinical research articles;
5. Articles written in languages not specified in the inclusion criteria.
Manuscripts that met the inclusion criteria were retained for full analysis. Any disagreements were resolved through further discussion involving an additional author.
The PubMed search identified 66,877 articles involving AML, of which 22 were eligible. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] The search in LILACS identified 582 articles and none of them were eligible.
Among the 22 studies selected, 34 patients presenting ring chromosome 11 were described ( Table 2 ). Gender and age were reported in 27/34 cases, with mean ages for women and men of 62 and 60 years and medians of 61 and 63 years, respectively.
The French-American-British (FAB) classification was given for 20/34 patients, and the distribution was: M0 (1 male), M1
(2 females and 2 males), M2 (2 females and 3 males and 1 gender not informed), M4 (3 females and 4 males), M5a (1 female) and M6 (1 female). Along with ring chromosome 11, all the 34 patients presented a complex karyotype.
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DISCUSSION
Although our patient satisfactorily tolerated chemotherapy and achieved complete remission after one cycle, a relapse occurred eight months later. The observed resistance to chemotherapy might be a possible explanation for treatment failure, but the expression of multidrug-resistant genes was not tested.
According to our records, obesity was the only lifestyle-related risk factor in cancer presented by our patient. She was considered to have class II/III obesity (body mass index, BMI > 35). Obesity is a chronic inflammatory condition, characterized by increased production of pro-inflammatory cytokines and adipokines, presence of hyperinsulinemia and insulin resistance and elevated levels of insulin-like growth factors. [1] [2] [3] 29 It has been suggested that obesity is an adverse prognostic marker in patients with cancer. 7, 8, 29, 30 It is well known that overweight and obesity are associated with increased incidence and mortality due to cardiovascular disease, diabetes mellitus and certain types of cancer, including leukemia. Epidemiological, case control and meta-analysis studies have Figure 4) . The molecular cytogenetic results were as follows: 46,XX, del(5)(q), r(11), t (11?;12;13) and der(13)t(11?;12;13). A new conditioning regimen (FLAG) was started, but the patient died due to septic shock in September 2011, 293 days after diagnosis.
Ethics committee approval: CAAE #56621716.5.0000.5259.
Review of ring chromosome 11 and AML
The literature was reviewed through the MEDLINE (PubMed) and LILACS databases (see Table 1 for details on strategy and results). For the LILACS database, the keywords in Portuguese were: "aberrações cromossômicas", "cariótipo complexo" and "leucemia mielóide aguda". In PubMed/MEDLINE we searched for "acute myeloid leukemia" and "chromosomic aberrations"
and "ring chromosome" and "case reports".
Articles were selected if they met the following inclusion criteria: "leucemia mieloide aguda" and "leucemia" and "mielóide", "aguda", "aberrações cromossômicas", "cariótipo complexo" 582 0
Ornellas MHF, Maioli MCP, Lucena SBSG, Bastos EF, Chaves TS, Melo KV, Ribeiro-Carvalho MM, Liehr T, Alves G Complex karyotype including ring chromosome 11 in a case of acute myeloid leukemia leukemia: case report reported to be poor, as was found in our case. 41 For the chromosomal abnormalities found here, i.e. ring chromosome and translocations, it needs to be noted that ring chromosomes are considered to be rare in hematopoietic cancer (less than 10%). 6 With regard to ring chromosome 11, this abnormality has only been found in 34 AML patients ( Table 2) . The outcomes of 26 of these 34 patients were not reported in the papers, but among the 8 with outcomes reported, 7 died, and only 1 was alive at the time of publication of the data. Our patient died nine months after admission. These data strongly suggest that presence of ring chromosome 11 is associated with poor prognosis in leukemia cases. partners have been identified, and it has been observed that MLL fusion proteins lose H3K4 methyltransferase activity, thus generating transformation capacity. 42 Unfortunately, we were unable to study the breakpoint cluster region involved in this case, and future studies will be necessary to elucidate whether ring chromosome 11 in leukemia cases carries a rearranged MLL gene and what the mechanism underlying its gene expression are.
CONCLUSION
Molecular cytogenetic analysis is suitable for better identification
and characterization of chromosomal rearrangements in acute leukemia. Single case reports, as well as population-based studies, are necessary for providing further insights into karyotypic changes that take place in human leukemogenesis.
